603538.SH
Ningbo Menovo Pharmaceutical Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 20.73
+1.97%Oct 21, 2026, 09:41 UTC
Ningbo Menovo Pharmaceutical appointed Guotai Haitong Securities Co., Ltd. as sponsor for its 2026 private placement of A shares, which took over Wanlian Securities' unfinished continuing-supervision work related to the 2021 convertible-bond proceeds.
Source:Oct 21, 2026, 09:41 UTC
Ningbo Menovo Pharmaceutical Co., Ltd., its subsidiary Zhejiang Menovo Pharmaceutical Co., Ltd., Guotai Haitong Securities Co., Ltd., and two bank branches signed four-party agreements to supervise proceeds from the 2021 convertible-bond offering; the designated accounts were unchanged.
Source:Oct 16, 2026, 10:33 UTC
China’s National Medical Products Administration approved Ningbo Menovo Tiankang Pharmaceutical’s tofacitinib citrate extended-release tablets and issued a drug registration certificate.
Source: